Trial Profile
A study investigating the population pharmacokinetics parameters of doripenem in patients from Korea with acute infections
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Oct 2015
Price :
$35
*
At a glance
- Drugs Doripenem (Primary)
- Indications Infections
- Focus Pharmacokinetics
- 29 Oct 2015 New trial record
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy